Congruence Therapeutics

Fierce Biotech's 2025 Fierce 15

From advancing radically new therapies to refining existing modalities, this year’s Fierce 15 companies are pushing the envelope and giving us a reason for optimism.

Gabrielle Masson Sep 22, 2025 8:00am

Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders

May 10, 2024 8:30am

Medical examination and growth graph data of business on tablet with doctors health report clipboard on background

Congruence to build team of 'drug hunters' with $50M funding

Feb 8, 2022 8:00am